These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2289706)

  • 21. Plasmatic parameters of fibrin formation and degradation in cancer patients: correlation between fibrinopeptide A and D-dimer.
    Sagripanti A; Carpi A; Baicchi U; Grassi B
    Biomed Pharmacother; 1993; 47(6-7):235-9. PubMed ID: 8061250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased thrombin-antithrombin III complexes after 1 h of physical exercise.
    Herren T; Bärtsch P; Haeberli A; Straub PW
    J Appl Physiol (1985); 1992 Dec; 73(6):2499-504. PubMed ID: 1490963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of soluble fibrin monomer-fibrinogen complex in plasmas derived from patients with various underlying clinical situations.
    Nakahara K; Kazahaya Y; Shintani Y; Yamazumi K; Eguchi Y; Koga S; Wada H; Matsuda M
    Thromb Haemost; 2003 May; 89(5):832-6. PubMed ID: 12719780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemodialysis and heparin. Alternative methods of measuring heparin and of detecting activation of coagulation.
    Ireland HA; Boisclair MD; Lane DA; Thompson E; Curtis JR
    Clin Nephrol; 1991 Jan; 35(1):26-33. PubMed ID: 1826095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A new advance in theory of blood coagulation and fibrinolysis and its practical application].
    Matsuno K; Araki K
    Rinsho Byori; 1991 Feb; 39(2):179-84. PubMed ID: 1904112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heamostatic and genetic predisposing factors for stroke in children with sickle cell anemia.
    Mourad H; Fadel W; El Batch M; Rowisha M
    Egypt J Immunol; 2008; 15(1):25-37. PubMed ID: 20306667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hypercoagulation and recurrence of cerebral infarct].
    Landi GL; Anzalone N; Morabito A; D'Angelo A; Mannucci PM
    G Clin Med; 1989; 70(6-7):415-6, 418-9. PubMed ID: 2527773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of a low molecular weight heparin (Fragmin) and of unfractionated heparin on coagulation activation at the site of plug formation in vivo.
    Eichinger S; Wolz M; Nieszpaur-Los M; Schneider B; Lechner K; Eichler HG; Kyrle PA
    Thromb Haemost; 1994 Dec; 72(6):831-5. PubMed ID: 7740450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma parameters of the prothrombotic state in chronic uremia.
    Sagripanti A; Cupisti A; Baicchi U; Ferdeghini M; Morelli E; Barsotti G
    Nephron; 1993; 63(3):273-8. PubMed ID: 8446263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations of haemostatic markers in various subtypes and phases of stroke.
    Yamazaki M; Uchiyama S; Maruyama S
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):707-12. PubMed ID: 7507362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic values of the factor Xa-activated clotting time and endogenous thrombin potential in patients suspected of having disseminated intravascular coagulation.
    Seo JW; Kim HK; Kim JE; Park S; Cho HI
    Thromb Res; 2009 Feb; 123(4):565-72. PubMed ID: 18479738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrin metabolism in patients with acute myocardial infarction during and after treatment with tissue-type plasminogen activator.
    Ring ME; Butman SM; Bruck DC; Feinberg WM; Corrigan JJ
    Thromb Haemost; 1988 Dec; 60(3):428-33. PubMed ID: 2976994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Blood coagulation activation in patients with ulcerative colitis].
    Swiatkowski M; Grad K; Kłopocka M; Budzyński J; Zekanowska E; Kotschy M
    Pol Arch Med Wewn; 2000; 103(1-2):47-51. PubMed ID: 11236258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formation of fibrin monomers in experimental disseminated intravascular coagulation and its inhibition by recombinant hirudin.
    Dickneite G; Czech J; Keuper H
    Circ Shock; 1994 Apr; 42(4):183-9. PubMed ID: 8055664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases].
    Murakoshi T
    Hokkaido Igaku Zasshi; 1982 May; 57(3):351-63. PubMed ID: 6957368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of coagulation test abnormalities to tumour burden and postoperative DVT in resected colorectal cancer.
    Iversen LH; Thorlacius-Ussing O
    Thromb Haemost; 2002 Mar; 87(3):402-8. PubMed ID: 11916070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Latent coagulation disorders evaluated by the assay of plasma thrombin-antithrombin III complexes in a large series of 'solid tumours'.
    Bartoloni C; Guidi L; Tricerri A; Patriarca F; Pili R; Cursi F; Canetta M; Cappelli A; Vangeli M; Salvati F
    Oncology; 1992; 49(6):426-30. PubMed ID: 1465280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Long-term hemodialysis and changes in variables of coagulation and fibrinolysis].
    Uchida Y
    Fukuoka Igaku Zasshi; 1991 Nov; 82(11):576-85. PubMed ID: 1774013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of methods for detecting soluble fibrin in plasma. An in vitro study.
    Halvorsen S; Skjønsberg OH; Ruyter R; Godal HC
    Thromb Res; 1990 Feb; 57(4):489-97. PubMed ID: 2326770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Off-pump coronary artery bypass operation does not increase procoagulant and fibrinolytic activity: preliminary results.
    Englberger L; Immer FF; Eckstein FS; Berdat PA; Haeberli A; Carrel TP
    Ann Thorac Surg; 2004 May; 77(5):1560-6. PubMed ID: 15111143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.